关注
Faiz Anwer
Faiz Anwer
Cleveland Clinic, Taussig Cancer Center
在 ccf.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Triplet therapy, transplantation, and maintenance until progression in myeloma
PG Richardson, SJ Jacobus, EA Weller, H Hassoun, S Lonial, NS Raje, ...
New England Journal of Medicine 387 (2), 132-147, 2022
2682022
Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review
A Russ, AB Hua, WR Montfort, B Rahman, IB Riaz, MU Khalid, JS Carew, ...
Blood reviews 32 (6), 480-489, 2018
1772018
Significant risk of graft-versus-host disease with exposure to checkpoint inhibitors before and after allogeneic transplantation
A Ijaz, AY Khan, SU Malik, W Faridi, MA Fraz, M Usman, MJ Tariq, S Durer, ...
Biology of Blood and Marrow Transplantation 25 (1), 94-99, 2019
1692019
Patterns of pancytopenia patients in a general medical ward and a proposed diagnostic approach
O Ishtiaq, HZ Baqai, F Anwer, N Hussain
Journal of Ayub Medical College Abbottabad 16 (1), 2004
1632004
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
S Mailankody, JV Matous, S Chhabra, M Liedtke, S Sidana, OO Oluwole, ...
Nature medicine 29 (2), 422-429, 2023
1252023
A review of autologous stem cell transplantation in lymphoma
U Zahid, F Akbar, A Amaraneni, M Husnain, O Chan, IB Riaz, A McBride, ...
Current hematologic malignancy reports 12, 217-226, 2017
1232017
Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system
HM Babiker, A McBride, M Newton, LM Boehmer, AG Drucker, M Gowan, ...
Critical reviews in oncology/hematology 126, 186-200, 2018
1052018
Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review
F Anwer, AA Shaukat, U Zahid, M Husnain, A McBride, D Persky, M Lim, ...
Immunotherapy 9 (2), 123-130, 2017
1012017
Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance
RM Usman, F Razzaq, A Akbar, AA Farooqui, A Iftikhar, A Latif, H Hassan, ...
Asia‐Pacific Journal of Clinical Oncology 17 (3), 193-208, 2021
962021
Brentuximab vedotin for treatment of non-Hodgkin lymphomas: a systematic review
GK Berger, A McBride, S Lawson, K Royball, S Yun, K Gee, IB Riaz, ...
Critical reviews in oncology/hematology 109, 42-50, 2017
782017
Relapse prevention with tyrosine kinase inhibitors after allogeneic transplantation for philadelphia chromosome–positive acute lymphoblast leukemia: A systematic review
Z Warraich, P Tenneti, T Thai, A Hubben, H Amin, A McBride, S Warraich, ...
Biology of Blood and Marrow Transplantation 26 (3), e55-e64, 2020
722020
Waldenström macroglobulinemia: review of pathogenesis and management
S Yun, AC Johnson, ON Okolo, SJ Arnold, A McBride, L Zhang, RC Baz, ...
Clinical Lymphoma Myeloma and Leukemia 17 (5), 252-262, 2017
602017
Treatment of relapsed multiple myeloma: Evidence-based recommendations
C Durer, S Durer, S Lee, R Chakraborty, MN Malik, A Rafae, MA Zar, ...
Blood Reviews 39, 100616, 2020
592020
Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte, F Anwer, CM Calton, ...
Leukemia 32 (1), 230-233, 2018
562018
Prevalence of Transfusion Transmissible Infections in Beta-Thalassemia Major Patients of Pakistan: A Systematic Review
H Ehsan, A Wahab, MA Shafqat, MS Faisal, A Muneeb, S Ali, MK Sana, ...
Blood 136, 23-25, 2020
532020
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies
R Iftikhar, F Anwer, K Neupane, A Rafae, SK Mahmood, T Ghafoor, ...
Blood reviews 47, 100772, 2021
512021
Universal updated phase 1 data validates the feasibility of allogeneic anti-BCMA ALLO-715 therapy for relapsed/refractory multiple myeloma
S Mailankody, M Liedtke, S Sidana, JV Matous, S Chhabra, OO Oluwole, ...
Blood 138, 651, 2021
412021
The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
ST Nawrocki, Y Han, V Visconte, B Przychodzen, CM Espitia, J Phillips, ...
Leukemia 33 (12), 2971-2974, 2019
402019
Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review
A Mushtaq, V Kapoor, A Latif, A Iftikhar, U Zahid, A McBride, I Abraham, ...
Critical reviews in oncology/hematology 125, 1-11, 2018
402018
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes
RT Swords, J Watts, HP Erba, JK Altman, M Maris, F Anwer, Z Hua, ...
Blood cancer journal 7 (2), e520-e520, 2017
402017
系统目前无法执行此操作,请稍后再试。
文章 1–20